Amneal Pharmaceuticals Inc (NYSE:AMRX)

18.22
Delayed Data
As of Jun 20
 -0.62 / -3.29%
Today’s Change
13.47
Today|||52-Week Range
25.70
+9.43%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Quarter 1
2018
Revenue and IncomeNet Revenues202.1M206.4M182.9M0.00
 
 
 
 
Cost of Goods Sold96.7M124.0M99.3M0.00
 
 
 
 
Depreciation And Amortization28.2M31.4M23.3M0.00
 
 
 
 
 
Operating ExpensesGross Income77.2M51.0M60.3M0.00
 
 
 
 
General Expenses80.8M69.4M80.4M0.00
 
 
 
 
Research And Development26.8M15.8M15.1M--
 
 
 
 
Total Operating Expenses205.7M224.8M203.0M0.00
 
 
 
 
 
Non-Operating ExpensesOperating Income-3.6M-18.5M-20.1M0.00
 
 
 
 
Extraordinary Credit0.000.0038.1M0.00
 
 
Extraordinary Charge-6.4M-25.7M-316.1M0.00
 
 
 
 
Interest Expense On Debt13.4M13.6M14.0M0.00
 
 
 
 
Other Expenses2.3M5.1M1.7M0.00
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-20.9M-52.4M-310.1M0.00
 
 
 
 
Income Taxes-520.0K-3.0M-9.0M0.00
 
 
 
 
Net Income-20.4M-49.4M-301.1M0.00
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS71.8M71.9M72.1M1.0K
 
 
 
 
 
Shares To Calculate EPS Diluted71.8M71.9M72.1M1.0K
 
 
 
 
 
 
Earnings Per ShareEPS-$0.28-$0.69-$4.18$0.00
 
 
 
 
EPS Diluted-$0.28-$0.69-$4.18$0.00